Christopher M. Bourne

419 total citations
17 papers, 263 citations indexed

About

Christopher M. Bourne is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Christopher M. Bourne has authored 17 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Immunology. Recurrent topics in Christopher M. Bourne's work include CAR-T cell therapy research (7 papers), Inflammasome and immune disorders (5 papers) and Immunotherapy and Immune Responses (3 papers). Christopher M. Bourne is often cited by papers focused on CAR-T cell therapy research (7 papers), Inflammasome and immune disorders (5 papers) and Immunotherapy and Immune Responses (3 papers). Christopher M. Bourne collaborates with scholars based in United States, Canada and Germany. Christopher M. Bourne's co-authors include David A. Scheinberg, Megan M. Dacek, Cornelius Y. Taabazuing, Thomas J. Gardner, Aaron Y. Chang, Tao Dao, Martin G. Klatt, Renier J. Brentjens, Bohdana M. Discher and Leila Peraro and has published in prestigious journals such as Blood, Science Advances and Developmental Biology.

In The Last Decade

Christopher M. Bourne

15 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher M. Bourne United States 10 150 121 92 59 44 17 263
Dimitrios Alatzoglou Switzerland 2 246 1.6× 137 1.1× 198 2.2× 63 1.1× 42 1.0× 3 409
Adrian Gottschlich Germany 7 129 0.9× 137 1.1× 140 1.5× 34 0.6× 13 0.3× 18 302
Gunjan Dagar India 8 156 1.0× 129 1.1× 64 0.7× 45 0.8× 37 0.8× 16 283
Hsin‐Yuan Cheng United States 9 138 0.9× 155 1.3× 158 1.7× 22 0.4× 51 1.2× 15 345
Matthew Bell United States 9 208 1.4× 203 1.7× 108 1.2× 64 1.1× 53 1.2× 16 394
Joel G. Rurik United States 6 94 0.6× 144 1.2× 80 0.9× 31 0.5× 49 1.1× 9 303
Chi Young United States 7 96 0.6× 117 1.0× 76 0.8× 23 0.4× 69 1.6× 20 289
Megan M. Dacek United States 8 147 1.0× 66 0.5× 69 0.8× 63 1.1× 43 1.0× 12 200
Yichen Zhu United States 12 233 1.6× 104 0.9× 152 1.7× 53 0.9× 27 0.6× 18 351
Qumiao Xu China 8 123 0.8× 109 0.9× 76 0.8× 23 0.4× 30 0.7× 16 219

Countries citing papers authored by Christopher M. Bourne

Since Specialization
Citations

This map shows the geographic impact of Christopher M. Bourne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Bourne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Bourne more than expected).

Fields of papers citing papers by Christopher M. Bourne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Bourne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Bourne. The network helps show where Christopher M. Bourne may publish in the future.

Co-authorship network of co-authors of Christopher M. Bourne

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Bourne. A scholar is included among the top collaborators of Christopher M. Bourne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Bourne. Christopher M. Bourne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Bourne, Christopher M. & Cornelius Y. Taabazuing. (2024). Harnessing Pyroptosis for Cancer Immunotherapy. Cells. 13(4). 346–346. 11 indexed citations
3.
Herrmann, Beatrice, Christopher M. Bourne, Daniel Sorobetea, et al.. (2024). Distinct sequential death complexes regulate pyroptosis and IL-1β release in response to Yersinia blockade of immune signaling. Science Advances. 10(30). eadl3629–eadl3629. 4 indexed citations
4.
Bourne, Christopher M., et al.. (2024). Inflammatory caspase substrate specificities. mBio. 15(7). e0297523–e0297523. 9 indexed citations
5.
Dacek, Megan M., et al.. (2023). Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPα checkpoint blocker. Blood. 141(16). 2003–2015. 29 indexed citations
6.
Bourne, Christopher M., Megan M. Dacek, Thomas J. Gardner, et al.. (2023). Host Interactions with Engineered T-cell Micropharmacies. Cancer Immunology Research. 11(9). 1253–1265. 3 indexed citations
7.
Bourne, Christopher M., et al.. (2023). The tetrapeptide sequence of IL-18 and IL-1β regulates their recruitment and activation by inflammatory caspases. Cell Reports. 42(12). 113581–113581. 40 indexed citations
8.
9.
Klatt, Martin G., Tao Dao, Zhiyuan Yang, et al.. (2022). A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies. Blood. 140(8). 861–874. 15 indexed citations
10.
Bourne, Christopher M., Tao Dao, Ron S. Gejman, et al.. (2022). Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment. Blood Advances. 6(14). 4107–4121. 6 indexed citations
11.
Peraro, Leila, Christopher M. Bourne, Megan M. Dacek, et al.. (2021). Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection. Molecular Therapy. 29(12). 3398–3409. 14 indexed citations
12.
Gardner, Thomas J., Christopher M. Bourne, Dinali Wijewarnasuriya, et al.. (2021). Engineering CAR-T cells to activate small-molecule drugs in situ. Nature Chemical Biology. 18(2). 216–225. 58 indexed citations
13.
Bourne, Christopher M., et al.. (2021). Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy. OncoImmunology. 10(1). 1916243–1916243. 18 indexed citations
14.
Klatt, Martin G., Zhiyuan Yang, Jianying Liu, et al.. (2020). A TCR Mimic Antibody-Directed CAR T Cell Specific for Intracellular NDC80 Is Broadly Cancer Reactive and Displays High Activity Against Hematological Malignancies. Blood. 136(Supplement 1). 20–21. 1 indexed citations
15.
Gardner, Thomas J., Christopher M. Bourne, Megan M. Dacek, et al.. (2020). Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug Delivery. Cancers. 12(8). 2175–2175. 19 indexed citations
16.
Oh, Claire Y., Martin G. Klatt, Christopher M. Bourne, et al.. (2019). ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome. Cancer Immunology Research. 7(12). 1984–1997. 31 indexed citations
17.
Bourne, Christopher M.. (1998). Unintended Consequences of the Goldwater-Nichols Act (Joint Force Quarterly, Spring 1998).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitrios Alatzoglou Breakdown of academic impact, for papers by Adrian Gottschlich Breakdown of academic impact, for papers by Gunjan Dagar Breakdown of academic impact, for papers by Hsin‐Yuan Cheng Breakdown of academic impact, for papers by Matthew Bell Breakdown of academic impact, for papers by Joel G. Rurik Breakdown of academic impact, for papers by Chi Young Breakdown of academic impact, for papers by Megan M. Dacek Breakdown of academic impact, for papers by Yichen Zhu Breakdown of academic impact, for papers by Qumiao Xu
Rankless by CCL
2026